Itonis Inc
Itonis, Inc., a development stage company, focuses on producing and marketing over the counter and prescription homeopathic preparations to treat common ailments and chronic diseases. The company intends to sells its over-the-counter to alleviate mild to moderate nausea. It has placed a manufacturing order for the first batch of its Emesyl product line. The company was formerly known as Kenshou, … Read more
Itonis Inc (ITNS) - Net Assets
Latest net assets as of May 2025: $-1.14 Million USD
Based on the latest financial reports, Itonis Inc (ITNS) has net assets worth $-1.14 Million USD as of May 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($137.21K) and total liabilities ($1.27 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-1.14 Million |
| % of Total Assets | -827.41% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 145.95 |
Itonis Inc - Net Assets Trend (2005–2024)
This chart illustrates how Itonis Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Itonis Inc (2005–2024)
The table below shows the annual net assets of Itonis Inc from 2005 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-11-30 | $-1.13 Million | -7.50% |
| 2023-11-30 | $-1.05 Million | +6.49% |
| 2022-11-30 | $-1.13 Million | -0.34% |
| 2021-11-30 | $-1.12 Million | -6.78% |
| 2020-11-30 | $-1.05 Million | -4.83% |
| 2019-11-30 | $-1.00 Million | -6.47% |
| 2018-11-30 | $-943.16K | -8.24% |
| 2017-11-30 | $-871.37K | -65.78% |
| 2016-11-30 | $-525.63K | -18.09% |
| 2015-11-30 | $-445.10K | -17.40% |
| 2014-11-30 | $-379.12K | -165.47% |
| 2013-11-30 | $579.12K | +142.60% |
| 2011-11-30 | $-1.36 Million | -25.73% |
| 2007-11-30 | $-1.08 Million | -173.74% |
| 2006-11-30 | $-395.01K | -457.36% |
| 2005-11-30 | $110.53K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Itonis Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 1509771100.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (November 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $1.64 Million | % |
| Other Components | $13.44 Million | % |
| Total Equity | $-1.13 Million | 100.00% |
Itonis Inc Competitors by Market Cap
The table below lists competitors of Itonis Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Hop-On Inc
PINK:HPNN
|
$3.71 |
|
Puissant Industries Inc
PINK:PSSS
|
$3.71 |
|
Hutn Inc
PINK:HUTN
|
$3.72 |
|
Molecular Pharmacology (USA) Ltd
PINK:MLPH
|
$3.73 |
|
Yippy Inc.
PINK:YIPI
|
$3.65 |
|
New Generation Consumer Group Inc
PINK:NGCG
|
$3.62 |
|
Livewire Ergogenics
PINK:LVVV
|
$3.62 |
|
Zenovia Digital Exchange Corporation
PINK:ZDEC
|
$3.61 |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Itonis Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from -1,054,737 to -1,133,885, a change of -79,148.
- Net loss of 9,628 reduced equity.
- Other comprehensive income increased equity by 1,596,909.
- Other factors decreased equity by 1,666,429.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-9.63K | -0.85% |
| Other Comprehensive Income | $1.60 Million | +140.84% |
| Other Changes | $-1.67 Million | -146.97% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Itonis Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2005-11-30 | $0.00 | $0.00 | x |
| 2006-11-30 | $-0.01 | $0.00 | x |
| 2007-11-30 | $-0.02 | $0.00 | x |
| 2016-11-30 | $0.00 | $0.00 | x |
| 2017-11-30 | $0.00 | $0.00 | x |
| 2018-11-30 | $0.00 | $0.00 | x |
| 2019-11-30 | $0.00 | $0.00 | x |
| 2020-11-30 | $0.00 | $0.00 | x |
| 2021-11-30 | $0.00 | $0.00 | x |
| 2022-11-30 | $0.00 | $0.00 | x |
| 2023-11-30 | $0.00 | $0.00 | x |
| 2024-11-30 | $0.00 | $0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Itonis Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -2798.84%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-61.50%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2005 | -1012.21% | 0.00% | 0.00x | 1.76x | $-1.13 Million |
| 2006 | 0.00% | -9454.55% | 0.30x | 0.00x | $-2.26 Million |
| 2007 | 0.00% | -676.08% | 8.31x | 0.00x | $-1.29 Million |
| 2010 | 0.00% | 0.00% | 0.00x | 0.00x | $-9.69K |
| 2011 | 0.00% | 0.00% | 0.00x | 0.00x | $-1.26 Million |
| 2013 | -33.27% | 0.00% | 0.00x | 1.59x | $-250.61K |
| 2014 | 0.00% | 0.00% | 0.00x | 0.00x | $-1.13 Million |
| 2015 | 0.00% | 0.00% | 0.00x | 0.00x | $-462.74K |
| 2016 | 0.00% | -93934.00% | 0.00x | 0.00x | $-370.14K |
| 2017 | 0.00% | -5026.65% | 0.13x | 0.00x | $-298.36K |
| 2018 | 0.00% | -787.46% | 0.16x | 0.00x | $22.52K |
| 2019 | 0.00% | -703.02% | 0.18x | 0.00x | $39.40K |
| 2020 | 0.00% | -1961.42% | 0.05x | 0.00x | $56.76K |
| 2021 | 0.00% | -1612.49% | 0.19x | 0.00x | $41.02K |
| 2022 | 0.00% | -248.30% | 0.16x | 0.00x | $105.22K |
| 2023 | 0.00% | -2127.32% | 0.02x | 0.00x | $67.16K |
| 2024 | 0.00% | -2798.84% | 0.00x | 0.00x | $103.76K |
Industry Comparison
This section compares Itonis Inc's net assets metrics with peer companies in the Medical Distribution industry.
Industry Context
- Industry: Medical Distribution
- Average net assets among peers: $1,254,633,395
- Average return on equity (ROE) among peers: -3.66%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Itonis Inc (ITNS) | $-1.14 Million | -1012.21% | N/A | $3.69 |
| Accendra Health Inc (ACH) | $314.40 Million | 8.91% | 1.75x | $22.90K |
| Arjo AB (publ) (ARRJF) | $6.88 Billion | 10.78% | 1.12x | $491.29 Million |
| Cardinal Health Inc (CAH) | $255.60 Million | 13.15% | 1.57x | $50.81 Billion |
| Cencora Inc. (COR) | $4.01 Billion | 11.02% | 2.01x | $62.31 Billion |
| Cosmos Health Inc. (COSM) | $36.04 Million | -51.45% | 0.83x | $8.90 Million |
| EDAP TMS SA (EDAP) | $50.05 Million | 1.40% | 0.54x | $115.72 Million |
| Empro Group Inc. Ordinary shares (EMPG) | $741.21K | -42.90% | 4.10x | $9.16 Million |
| Energy Management International Inc (ENMI) | $-362.21K | 0.00% | 0.00x | $383.13K |
| Exlites Holdings International Inc (EXHI) | $-84.27 | 0.00% | 0.00x | $574.58K |
| Galenica AG (GALNF) | $999.54 Million | 12.50% | 1.21x | $3.75 Billion |